Media Contact:

Sarah Spielvogel
Novo Nordisk
609-786-4278
sspv@novonordisk.com

IZOD IndyCar Series driver Charlie Kimball
IZOD IndyCar Series driver Charlie Kimball
Race with Insulin® logo
Race with Insulin® logo

Novo Nordisk Launches New “Race with Insulin®” Sweepstakes Asking People to Create Their Own “Pit Crew”

Enter today for a chance to win a trip to the 2013 IndyCar® Series finale

Birmingham, Ala. (April 5, 2013) /PRNewswire/ — Novo Nordisk, a world leader in diabetes care, and IZOD IndyCar Series driver Charlie Kimball today kicked off a new contest asking people to support Charlie by encouraging their friends and family to join the Race with Insulin® crew. Now through September 15, by sharing Kimball’s story about the importance of team support with two or more friends or family, you can enter for a chance to win a trip to the 2013 IndyCar finale.

”It takes an entire crew to help me manage both my car and my diabetes, so we can compete at the highest levels,” said Kimball. “This program is a great way for people to show support, especially for friends and family affected by diabetes, and encourage them to share my story.”

Kimball is the first licensed driver with diabetes to race at the highest level of the series. Diagnosed with diabetes during a routine physician’s visit in 2007 while racing in Europe, he strategized with his doctor and his team to create some innovative solutions for keeping him safe and healthy on the track. Along with diet, exercise and the support of his crew, Charlie uses NovoLog® FlexPen® (insulin aspart [rDNA origin] injection) and a continuous glucose monitor to help manage his blood sugar before and during races, so that while he’s in the car, he can focus on driving.

Participants can enter by going to www.RaceWithInsulin.com/crew, visiting the Race with Insulin® exhibit in the IndyCar Fan Village at select IZOD IndyCar Series races, or via mail. The grand prize winner and three friends will join Kimball’s crew for a three-day/two-night trip to Southern California for the IndyCar World Championship on October 19, 2013.

The package includes round trip transportation to Los Angeles, hotel accommodations, VIP tickets to the race, and four IndyCar two-seater rides. Ten first prize winners will also receive an autographed Charlie Kimball Official die cast of Kimball’s car. One Grand Prize Winner and 10 First Prize winners will be selected in a random drawing on or about September 25, 2013.

For Official Rules, visit www.racewithinsulin.com. Prize winners must meet eligibility criteria. You can also follow Charlie on Twitter at @RaceWithInsulin.

Please see updated Important Safety Information below, including use with thiazolidinediones (TZDs).

Indications and Usage
What is NovoLog® (insulin aspart [rDNA origin] injection)?

Important Safety Information
Who should not use NovoLog®?

What should I tell my health care provider before taking NovoLog®?

How should I take NovoLog®?

What should I consider while using NovoLog®?

What are the possible side effects of NovoLog®?

Please visit novolog.com for Prescribing Information.

*Certain restrictions apply. See official rules for entry information.

About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global health care company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk-us.com or follow our news in the US on Twitter: @NovoNordiskUS.

About Diabetes
In the United States, 25.8 million people have diabetes, a condition in which the body does not produce enough or properly use insulin, the hormone needed to convert sugar, starches and other food into energy needed for daily life.

Race with Insulin®, NovoLog®, and FlexPen® are registered trademarks of Novo Nordisk A/S.

©2013 Novo Nordisk All Rights Reserved 0313-00013922-1 April 2013